BRAF and pleomorphic xanthoastrocytoma: Therefore, the combination of CD34 positivity and BRAF V600E mutation we report raises ganglioglioma, pleomorphic xanthoastrocytoma, and dysembryoplastic neuroepithelial tumor as differential diagnostic considerations.